Stocks
AbbVie (ABBV) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 23 933 | 24 174 | 17 172 | 14 910 | 17 629 | 16 921 | ||
| Changes by years, y/y, % | +94% | +1% | -29% | -13% | +18% | +7.4% | |||
AbbVie. EBITDA US GAAP, bln rub
AbbVie. EBITDA US GAAP, changes, %
AbbVie. EBITDA US GAAP, sum by quarters, bln rub
AbbVie (ABBV) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 4 344 | 3 516 | 5 369 | 3 692 | 8 659 | 16 921 | |
| Changes by years, y/y, % | -13% | -28% | +904% | -16% | +99% | |||
| Changes by quarters, q/q, % | -1% | -19% | +53% | -31% | +135% | |||
